An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Researchers have introduced groundbreaking tools—from a microfluidic platform measuring breast cell 'mechanical age' to AI-driven mammogram risk assessments—that could transform breast cancer ...
Live Science on MSN
New blood test aims to spot liver scarring before it paves the way to cancer
Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.
{image id=1352663 align=left size=large byline=true caption="The Massachusetts General Hospital, home to Mass Eye and Ear and part of the Mass General Brigham system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results